Author:
Edwards Beatrice J.,Raisch Dennis W.,Saraykar Smita S.,Sun Ming,Hammel Josh A.,Tran Hai T.,Wehr Nathaniel,Arabyat Rasha,West Dennis P.
Funder
University of Texas MD Anderson Cancer Center (US)
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. Rubin AI, Chen EH, Ratner D. Basal-cell carcinoma. N Engl J Med. 2005;353(21):2262–9.
2. National Cancer Institute at the National Institutes of Health. Skin cancer. 2014. http://www.cancer.gov/cancertopics/types/skin . Accessed 20 Dec 2016.
3. Miller SJ, Alam M, Andersen J, Berg D, Bichakjian CK, Bowen G, et al. Basal cell and squamous cell skin cancers. J Natl Compr Cancer Netw. 2010;8(8):836–64.
4. Axelson M, Liu K, Jiang X, He K, Wang J, Zhao H, et al. US Food and Drug Administration approval: vismodegib for recurrent, locally advanced, or metastatic basal cell carcinoma. Clin Cancer Res. 2013;19(9):2289–93.
5. Sekulic A, Migden MR, Oro AE, Dirix L, Lewis KD, Hainsworth JD, et al. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med. 2012;366(23):2171–9.
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献